Top compounds associated with response to TIGD5


Feature Type Standardized
Nominal ANOVA
mRNA Rapamycin gCSI pan-cancer AAC -0.16 0.004
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.1 0.004
mRNA Ko-143 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA tivozanib GDSC1000 pan-cancer AAC 0.095 0.005
mRNA AP-24534 GDSC1000 pan-cancer AAC 0.093 0.005
mRNA CD-1530 CTRPv2 pan-cancer AAC 0.11 0.005
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.098 0.005
mRNA ruxolitinib GDSC1000 pan-cancer AAC 0.091 0.005
mRNA BRD-K26531177 CTRPv2 pan-cancer AAC 0.1 0.005
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.006
Download CSV